Marker Therapeutics (MRKR) FCF Margin (QoQ) (2022 - 2025)
Marker Therapeutics (MRKR) FCF Margin (QoQ) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.94 Bn | 132.09 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.59 Bn | 78.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.67 Bn | 60.49 Bn | 1.37 Bn |
| 4 | Moderna | 57.81 Bn | 52.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.41 Bn | 10.02 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - |
| 10 | Marker Therapeutics | 27.33 Mn | 15.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,970.00 |
| Sep 30, 2025 | -379.00 |
| Jun 30, 2025 | 135,727.00 |
| Mar 31, 2025 | -136,652.00 |
| Dec 31, 2024 | -27,104.00 |
| Sep 30, 2024 | 24,055.00 |
| Jun 30, 2024 | 13,006.00 |
| Sep 30, 2023 | -293,439.00 |
| Jun 30, 2023 | 49,587.00 |
| Mar 31, 2023 | 29,604.00 |
| Dec 31, 2022 | -9,154.00 |
| Sep 30, 2022 | -63,770.00 |
| Jun 30, 2022 | 170,129.00 |